
Zene (株式会社Zene)
Zene (株式会社Zene)
Claim
Zene is a startup that determines "lifetime invariant disease risk" through individual genetic analysis and supports countermeasures. The difference between the company's genetic analysis service and conventional genetic testing is that it uses a "polygenic risk score method" that comprehensively analyzes the entire genomic information. Instead of the conventional method of dividing several genes by type and providing the proportion of diseased people, AI is used to comprehensively test more gen Show MoreZene is a startup that determines "lifetime invariant disease risk" through individual genetic analy Show More
Alpha Score
$ 0.39 M
Alpha Score
53.4
Predictions
Overview
Team
Financials
- Partnerships
Relationships
Locations
Competitors
Comparison
News
Product
Regulatory
Clinical
Patent
Publications
Notes
0and0